Stocks and Investing Stocks and Investing
Thu, March 23, 2023

Ed Arce Maintained (CDTX) at Strong Buy with Decreased Target to $120 on, Mar 23rd, 2023


Published on 2024-10-28 02:23:28 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Decreased Target from $130 to $120 on, Mar 23rd, 2023.

Ed has made no other calls on CDTX in the last 4 months.



There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $100 on, Wednesday, March 8th, 2023
Contributing Sources